These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29927744)

  • 21. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?
    Schlumberger M
    J Nucl Med; 1992 Jan; 33(1):172-3. PubMed ID: 1571042
    [No Abstract]   [Full Text] [Related]  

  • 22. Analytical and clinical performance of thyroglobulin autoantibody assays in thyroid cancer follow-up.
    Katrangi W; Grebe SKG; Algeciras-Schimnich A
    Clin Chem Lab Med; 2017 Oct; 55(12):1987-1994. PubMed ID: 28672730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How to manage patients with differentiated thyroid cancer and a rising serum thyroglobulin level.
    Elisei R; Agate L; Viola D; Matrone A; Biagini A; Molinaro E
    Endocrinol Metab Clin North Am; 2014 Jun; 43(2):331-44. PubMed ID: 24891165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroglobulin measurement in the management of patients with differentiated thyroid cancer.
    Algeciras-Schimnich A
    Crit Rev Clin Lab Sci; 2018 May; 55(3):205-218. PubMed ID: 29546779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. False-positive results corrected by the use of heterophilic antibody-blocking reagent in thyroglobulin immunoassays.
    Massart C; Corcuff JB; Bordenave L
    Clin Chim Acta; 2008 Feb; 388(1-2):211-3. PubMed ID: 17963702
    [No Abstract]   [Full Text] [Related]  

  • 26. Can thyroglobulin assay really supplant radioiodine scans in patients with differentiated thyroid cancer?
    Castagnoli A; Cappelli G; D'Agata A; Forni S; Milani S; Pupi A
    Lancet; 1982 Mar; 1(8271):573-4. PubMed ID: 6120429
    [No Abstract]   [Full Text] [Related]  

  • 27. Thyroglobulin in patients with differentiated thyroid carcinoma.
    Lindegaard MW; Paus E
    Scand J Clin Lab Invest Suppl; 1991; 206():79-84. PubMed ID: 1947763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroglobulin and thyroid cancer.
    Black EG; Hoffenberg R
    Lancet; 1982 Apr; 1(8277):914. PubMed ID: 6122134
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diagnostic accuracy of the serum thyroglobulin determinations and isotopic scanning in differentiated carcinomas of the thyroid with more than 5 years of follow-up].
    Pulgar Encinas R; Torné Poyatos P; Escobar Jiménez F; Olea Serrano N; Torres Vela E; García Puche JL
    Med Clin (Barc); 1988 May; 91(1):7-10. PubMed ID: 3172898
    [No Abstract]   [Full Text] [Related]  

  • 30. [Thyroglobulin as a tumor marker].
    Inada M
    Nihon Rinsho; 1980 Dec; 38(12):4647-51. PubMed ID: 7253242
    [No Abstract]   [Full Text] [Related]  

  • 31. Multiplexed immunoassay of thyroglobulin autoantibodies in patients with differentiated thyroid carcinoma.
    Giovanella L; Toffalori E; Tozzoli R; Caputo M; Ceriani L; Verburg FA
    Head Neck; 2012 Oct; 34(10):1369-71. PubMed ID: 22083639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum thyroglobulin levels in patients with differentiated thyroid carcinoma.
    Van Herle AJ
    Ann Radiol (Paris); 1977; 20(8):743-5. PubMed ID: 610543
    [No Abstract]   [Full Text] [Related]  

  • 33. Markedly elevated serum thyroglobulin associated with heterophile antibodies: a cautionary tale.
    Ding L; Shankara-Narayana N; Wood C; Ward P; Sidhu S; Clifton-Bligh R
    Thyroid; 2013 Jun; 23(6):771-2. PubMed ID: 23294194
    [No Abstract]   [Full Text] [Related]  

  • 34. The usefulness of serum thyroglobulin in the follow-up of differentiated thyroid carcinoma in children.
    Kirk JM; Mort C; Grant DB; Touzel RJ; Plowman N
    Med Pediatr Oncol; 1992; 20(3):201-8. PubMed ID: 1574029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caveat in the use of serum thyroglobulin determinations for monitoring differentiated thyroid carcinoma.
    Schwartz MA
    Clin Chem; 1980 May; 26(6):794. PubMed ID: 7371174
    [No Abstract]   [Full Text] [Related]  

  • 36. A low thyroglobulin level cannot be used to avoid adjuvant 131I therapy after thyroidectomy for thyroid carcinoma.
    Zanotti-Fregonara P; Grassetto G; Hindié E; Rubello D
    Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):169-71. PubMed ID: 18850097
    [No Abstract]   [Full Text] [Related]  

  • 37. Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies.
    Spencer CA
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3702-4. PubMed ID: 15292292
    [No Abstract]   [Full Text] [Related]  

  • 38. Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood.
    Ringel MD; Ladenson PW; Levine MA
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4435-42. PubMed ID: 9851791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroglobulin and thyroid cancer.
    Lo Gerfo P; Birnbaum S; Li Volsi V; Scholes J
    Surg Forum; 1977; 28():133-5. PubMed ID: 617395
    [No Abstract]   [Full Text] [Related]  

  • 40. High-sensitive basal serum thyroglobulin 6-12 months after thyroid ablation is strongly associated with early response to therapy and event-free survival in patients with low-to-intermediate risk differentiated thyroid carcinomas.
    Trimboli P; Zilioli V; Imperiali M; Ceriani L; Giovanella L
    Eur J Endocrinol; 2017 May; 176(5):497-504. PubMed ID: 28137736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.